X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Turkish Cargo Carried 100 million Vaccine Doses to All Around the World

Content Team by Content Team
9th July 2021
in Packaging & Logistic, Press Statements
Turkish Cargo Carried 100 million Vaccine Doses to All Around the World

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

As the cargo company that flies to more countries than any other, Turkish Cargo continues to fly uninterrupted and contributes to the fight against the pandemic for the return to better days. Managing to grow under the leadership of Turkish Airlines Chairman of the Board and the Executive Committee, M. ?lker Ayc? despite the shrinking sector during the pandemic, global air cargo brand also carries an important mission for the vaccine transportation. With its strong fleet, wide flight network and great service quality, Turkish Cargo delivered 100 million Covid-19 vaccine doses to more than 35 countries around the world.

M. ?lker Ayc?; “Turkish Cargo Is an Advantage for Our World”

On the topic, Turkish Airlines Chairman of the Board and the Executive Committee, M. ?lker Ayc? stated; “As the pandemic is an unprecedented threat to the human health, our Turkish Cargo brand is a significant advantage when it comes to combatting this threat. Our brand is able to carry vaccine doses to more than 100 countries with its international air bridge, becoming a lifeline for countries that are located too far from the ones with vaccine production facilities. Proving itself with hundreds of vaccine transportation operations to countries all around the world ranging from China to Brazil, India to Democratic Republic of the Congo along with operations to our own country, Turkish Cargo showed its reliability by transporting 100 million doses. With these successful operations, we increased our global market share to 7.5 percent in pharmaceutical transportation and became one of the most active carriers in vaccine transportation. Concurrent with the application of the vaccines which increases every day, we will continue to shoulder this responsibility until we win this battle against the pandemic.”

With the start of the vaccine distribution, Turkish Cargo carried 100 million vaccine doses, which is approximately 450 tonnes, from the vaccine production centres to destinations in its wide flight network with over 250 flights. Air cargo carrier transported the Covid-19 vaccines to key and certificated destinations such as Turkey, Baku, Rome, Belgrade, Copenhagen, Miami, Sao Paulo and Mexico City, creating a global corridor between more than 400 destinations. With 30 years of experience when it comes to special cargo transportation, successful brand proved its capability with vaccines that have different transportation requirements by carrying 7 different Covid-19 vaccines in containers with special cooling systems.

Previous Post

Tech Mahindra partners StaTwig for blockchain-based traceability solution for vaccine supply chain

Next Post

Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
The Falling Graph of Dose Contract Manufacturing

Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In